![](/img/cover-not-exists.png)
Both CD4 and CD8 T Cells Mediate Equally Effective In Vivo Tumor Treatment When Engineered with a Highly Avid TCR Targeting Tyrosinase
Frankel, T. L., Burns, W. R., Peng, P. D., Yu, Z., Chinnasamy, D., Wargo, J. A., Zheng, Z., Restifo, N. P., Rosenberg, S. A., Morgan, R. A.Volume:
184
Language:
english
Journal:
The Journal of Immunology
DOI:
10.4049/jimmunol.1000189
Date:
June, 2010
File:
PDF, 1.98 MB
english, 2010